Which has stronger earnings & valuation, GLAS or ACOG?

Glass House Brands has higher revenue and earnings than Alpha Cognition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Glass House Brands $176.02M 4.60 N/A N/A N/A Alpha Cognition $10.22M 17.96 -$20.67M -$1.35 N/A

Which has better valuation & earnings, ACOG or CYRX?

CryoPort has higher revenue and earnings than Alpha Cognition. Alpha Cognition is trading at a lower price-to-earnings ratio than CryoPort, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alpha Cognition $10.22M 17.96 -$20.67M -$1.35 N/A CryoPort $176.18M 4.43 $78.30M $1.35 11.47

Does the media favor ACOG or CYRX?

In the previous week, Alpha Cognition had 2 more articles in the media than CryoPort. MarketBeat recorded 5 mentions for Alpha Cognition and 3 mentions for CryoPort. Alpha Cognition's average media sentiment score of 0.91 beat CryoPort's score of 0.79 indicating that Alpha Cognition is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Cognition 2 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CryoPort 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ACOG or DSGN?

In the previous week, Alpha Cognition and Alpha Cognition both had 5 articles in the media. Alpha Cognition's average media sentiment score of 0.91 beat Design Therapeutics' score of 0.70 indicating that Alpha Cognition is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Cognition 2 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Design Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ACOG or MNPR?

In the previous week, Alpha Cognition had 3 more articles in the media than Monopar Therapeutics. MarketBeat recorded 5 mentions for Alpha Cognition and 2 mentions for Monopar Therapeutics. Alpha Cognition's average media sentiment score of 0.91 beat Monopar Therapeutics' score of 0.89 indicating that Alpha Cognition is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alpha Cognition 2 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Monopar Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Alpha Cognition (ACOG) Competitors

$8.43 +0.15 (+1.81%)

Closing price 08/3/2026 04:00 PM Eastern

Extended Trading

$8.38 -0.04 (-0.53%)

As of 08/3/2026 07:34 PM Eastern

Compare

ACOG vs. GLAS, CYRX, DSGN, AURA, and MNPR

Should you buy Alpha Cognition stock or one of its competitors? MarketBeat compares Alpha Cognition with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alpha Cognition include Glass House Brands (GLAS), CryoPort (CYRX), Design Therapeutics (DSGN), Aura Biosciences (AURA), and Monopar Therapeutics (MNPR).

How does Alpha Cognition compare to Glass House Brands?

Glass House Brands (NYSE:GLAS) and Alpha Cognition (NASDAQ:ACOG) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, media sentiment, profitability and risk.

Glass House Brands has higher revenue and earnings than Alpha Cognition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Glass House Brands	$176.02M	4.60	N/A	N/A	N/A
Alpha Cognition	$10.22M	17.96	-$20.67M	-$1.35	N/A

Glass House Brands has a net margin of 0.00% compared to Alpha Cognition's net margin of -232.23%. Glass House Brands' return on equity of 0.00% beat Alpha Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Glass House Brands	N/A	N/A	N/A
Alpha Cognition	-232.23%	-58.35%	-45.99%

In the previous week, Alpha Cognition had 5 more articles in the media than Glass House Brands. MarketBeat recorded 5 mentions for Alpha Cognition and 0 mentions for Glass House Brands. Alpha Cognition's average media sentiment score of 0.91 beat Glass House Brands' score of 0.00 indicating that Alpha Cognition is being referred to more favorably in the news media.

Company	Overall Sentiment
Glass House Brands	Neutral
Alpha Cognition	Positive

Glass House Brands currently has a consensus target price of $17.00, indicating a potential upside of 68.42%. Alpha Cognition has a consensus target price of $16.00, indicating a potential upside of 89.80%. Given Alpha Cognition's stronger consensus rating and higher possible upside, analysts plainly believe Alpha Cognition is more favorable than Glass House Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glass House Brands	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Alpha Cognition	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Alpha Cognition beats Glass House Brands on 6 of the 11 factors compared between the two stocks.

How does Alpha Cognition compare to CryoPort?

Alpha Cognition (NASDAQ:ACOG) and CryoPort (NASDAQ:CYRX) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings.

92.9% of CryoPort shares are owned by institutional investors. 8.6% of Alpha Cognition shares are owned by company insiders. Comparatively, 9.5% of CryoPort shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

CryoPort has a net margin of 41.57% compared to Alpha Cognition's net margin of -232.23%. CryoPort's return on equity of -7.92% beat Alpha Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Cognition	-232.23%	-58.35%	-45.99%
CryoPort	41.57%	-7.92%	-4.79%

Alpha Cognition has a beta of 2.3, indicating that its share price is 130% more volatile than the broader market. Comparatively, CryoPort has a beta of 1.89, indicating that its share price is 89% more volatile than the broader market.

In the previous week, Alpha Cognition had 2 more articles in the media than CryoPort. MarketBeat recorded 5 mentions for Alpha Cognition and 3 mentions for CryoPort. Alpha Cognition's average media sentiment score of 0.91 beat CryoPort's score of 0.79 indicating that Alpha Cognition is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Cognition	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CryoPort	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CryoPort has higher revenue and earnings than Alpha Cognition. Alpha Cognition is trading at a lower price-to-earnings ratio than CryoPort, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Cognition	$10.22M	17.96	-$20.67M	-$1.35	N/A
CryoPort	$176.18M	4.43	$78.30M	$1.35	11.47

Alpha Cognition currently has a consensus price target of $16.00, indicating a potential upside of 89.80%. CryoPort has a consensus price target of $16.38, indicating a potential upside of 5.71%. Given Alpha Cognition's stronger consensus rating and higher possible upside, equities research analysts clearly believe Alpha Cognition is more favorable than CryoPort.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Cognition	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
CryoPort	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

Summary

CryoPort beats Alpha Cognition on 10 of the 16 factors compared between the two stocks.

How does Alpha Cognition compare to Design Therapeutics?

Alpha Cognition (NASDAQ:ACOG) and Design Therapeutics (NASDAQ:DSGN) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, valuation, profitability, dividends and risk.

Alpha Cognition has higher revenue and earnings than Design Therapeutics. Design Therapeutics is trading at a lower price-to-earnings ratio than Alpha Cognition, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Cognition	$10.22M	17.96	-$20.67M	-$1.35	N/A
Design Therapeutics	N/A	N/A	-$69.79M	-$1.20	N/A

Design Therapeutics has a net margin of 0.00% compared to Alpha Cognition's net margin of -232.23%. Design Therapeutics' return on equity of -33.07% beat Alpha Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Cognition	-232.23%	-58.35%	-45.99%
Design Therapeutics	N/A	-33.07%	-31.29%

In the previous week, Alpha Cognition and Alpha Cognition both had 5 articles in the media. Alpha Cognition's average media sentiment score of 0.91 beat Design Therapeutics' score of 0.70 indicating that Alpha Cognition is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Cognition	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Design Therapeutics	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

56.6% of Design Therapeutics shares are held by institutional investors. 8.6% of Alpha Cognition shares are held by company insiders. Comparatively, 17.1% of Design Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Alpha Cognition has a beta of 2.3, suggesting that its share price is 130% more volatile than the broader market. Comparatively, Design Therapeutics has a beta of 1.63, suggesting that its share price is 63% more volatile than the broader market.

Alpha Cognition currently has a consensus target price of $16.00, indicating a potential upside of 89.80%. Design Therapeutics has a consensus target price of $16.50, indicating a potential upside of 29.31%. Given Alpha Cognition's stronger consensus rating and higher probable upside, research analysts plainly believe Alpha Cognition is more favorable than Design Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Cognition	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
Design Therapeutics	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.88

Summary

Design Therapeutics beats Alpha Cognition on 8 of the 15 factors compared between the two stocks.

How does Alpha Cognition compare to Aura Biosciences?

Aura Biosciences (NASDAQ:AURA) and Alpha Cognition (NASDAQ:ACOG) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

In the previous week, Alpha Cognition had 5 more articles in the media than Aura Biosciences. MarketBeat recorded 5 mentions for Alpha Cognition and 0 mentions for Aura Biosciences. Alpha Cognition's average media sentiment score of 0.91 beat Aura Biosciences' score of 0.00 indicating that Alpha Cognition is being referred to more favorably in the news media.

Company	Overall Sentiment
Aura Biosciences	Neutral
Alpha Cognition	Positive

Aura Biosciences presently has a consensus price target of $20.50, indicating a potential upside of 191.19%. Alpha Cognition has a consensus price target of $16.00, indicating a potential upside of 89.80%. Given Aura Biosciences' higher probable upside, equities analysts clearly believe Aura Biosciences is more favorable than Alpha Cognition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aura Biosciences	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Alpha Cognition	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Alpha Cognition has higher revenue and earnings than Aura Biosciences. Alpha Cognition is trading at a lower price-to-earnings ratio than Aura Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aura Biosciences	N/A	N/A	-$106.19M	-$1.74	N/A
Alpha Cognition	$10.22M	17.96	-$20.67M	-$1.35	N/A

Aura Biosciences has a beta of 0.4, suggesting that its share price is 60% less volatile than the broader market. Comparatively, Alpha Cognition has a beta of 2.3, suggesting that its share price is 130% more volatile than the broader market.

96.8% of Aura Biosciences shares are held by institutional investors. 1.9% of Aura Biosciences shares are held by company insiders. Comparatively, 8.6% of Alpha Cognition shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Aura Biosciences has a net margin of 0.00% compared to Alpha Cognition's net margin of -232.23%. Alpha Cognition's return on equity of -58.35% beat Aura Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aura Biosciences	N/A	-78.12%	-64.08%
Alpha Cognition	-232.23%	-58.35%	-45.99%

Summary

Alpha Cognition beats Aura Biosciences on 11 of the 15 factors compared between the two stocks.

How does Alpha Cognition compare to Monopar Therapeutics?

Alpha Cognition (NASDAQ:ACOG) and Monopar Therapeutics (NASDAQ:MNPR) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation.

Monopar Therapeutics has a net margin of 0.00% compared to Alpha Cognition's net margin of -232.23%. Monopar Therapeutics' return on equity of -12.84% beat Alpha Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Cognition	-232.23%	-58.35%	-45.99%
Monopar Therapeutics	N/A	-12.84%	-12.57%

1.8% of Monopar Therapeutics shares are owned by institutional investors. 8.6% of Alpha Cognition shares are owned by insiders. Comparatively, 9.7% of Monopar Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Alpha Cognition had 3 more articles in the media than Monopar Therapeutics. MarketBeat recorded 5 mentions for Alpha Cognition and 2 mentions for Monopar Therapeutics. Alpha Cognition's average media sentiment score of 0.91 beat Monopar Therapeutics' score of 0.89 indicating that Alpha Cognition is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alpha Cognition	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Monopar Therapeutics	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Alpha Cognition currently has a consensus price target of $16.00, indicating a potential upside of 89.80%. Monopar Therapeutics has a consensus price target of $112.08, indicating a potential upside of 0.40%. Given Alpha Cognition's higher probable upside, research analysts clearly believe Alpha Cognition is more favorable than Monopar Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Cognition	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
Monopar Therapeutics	1 Sell rating(s)	0 Hold rating(s)	10 Buy rating(s)	3 Strong Buy rating(s)	3.07

Monopar Therapeutics has lower revenue, but higher earnings than Alpha Cognition. Monopar Therapeutics is trading at a lower price-to-earnings ratio than Alpha Cognition, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Cognition	$10.22M	17.96	-$20.67M	-$1.35	N/A
Monopar Therapeutics	N/A	N/A	-$13.72M	-$1.90	N/A

Alpha Cognition has a beta of 2.3, indicating that its share price is 130% more volatile than the broader market. Comparatively, Monopar Therapeutics has a beta of 1.47, indicating that its share price is 47% more volatile than the broader market.

Summary

Monopar Therapeutics beats Alpha Cognition on 9 of the 16 factors compared between the two stocks.

Get Alpha Cognition News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ACOG vs. The Competition

Export

Metric	Alpha Cognition	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$180.29M	$11.61B	$6.86B	$12.44B
Dividend Yield	N/A	2.73%	2.60%	10.03%
P/E Ratio	-6.24	793.98	280.74	24.99
Price / Sales	17.96	731.95	588.16	90.43
Price / Cash	N/A	14.82	28.64	34.82
Price / Book	2.93	10.39	11.02	6.21
Net Income	-$20.67M	$2.80B	$3.48B	$347.49M
7 Day Performance	0.24%	0.76%	0.81%	1.29%
1 Month Performance	6.84%	-3.80%	-4.15%	-3.59%
1 Year Performance	-3.55%	154.73%	61.47%	18.38%

Alpha Cognition Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ACOG Alpha Cognition	4.2421 of 5 stars	$8.43 +1.8%	$16.00 +89.8%	-6.9%	$180.29M	$10.22M	N/A	N/A
GLAS Glass House Brands	N/A	$9.42 -4.8%	$17.00 +80.5%	N/A	$755.84M	$176.02M	N/A	N/A	Gap Up High Trading Volume
CYRX CryoPort	2.4752 of 5 stars	$14.93 -1.6%	$16.38 +9.7%	+113.1%	$752.47M	$176.18M	11.06	1,186	Upcoming Earnings
DSGN Design Therapeutics	2.2758 of 5 stars	$12.01 +1.2%	$16.50 +37.4%	+234.0%	$750.15M	N/A	N/A	40	News Coverage Positive News Earnings Report Upcoming Earnings Gap Up
AURA Aura Biosciences	2.0705 of 5 stars	$7.01 -0.6%	$20.50 +192.4%	+4.5%	$724.76M	N/A	N/A	50

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ACOG) was last updated on 8/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alpha Cognition (ACOG) Competitors

ACOG vs. GLAS, CYRX, DSGN, AURA, and MNPR

How does Alpha Cognition compare to Glass House Brands?

Summary

How does Alpha Cognition compare to CryoPort?

Summary

How does Alpha Cognition compare to Design Therapeutics?

Summary

How does Alpha Cognition compare to Aura Biosciences?

Summary

How does Alpha Cognition compare to Monopar Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACOG vs. The Competition

Alpha Cognition Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alpha Cognition (ACOG) Competitors

ACOG vs. GLAS, CYRX, DSGN, AURA, and MNPR

How does Alpha Cognition compare to Glass House Brands?

Which has stronger earnings & valuation, GLAS or ACOG?

Is GLAS or ACOG more profitable?

Does the media favor GLAS or ACOG?

Do analysts prefer GLAS or ACOG?

Summary

How does Alpha Cognition compare to CryoPort?

Do institutionals & insiders have more ownership in ACOG or CYRX?

Is ACOG or CYRX more profitable?

Which has more volatility & risk, ACOG or CYRX?

Does the media favor ACOG or CYRX?

Which has better valuation & earnings, ACOG or CYRX?

Do analysts recommend ACOG or CYRX?

Summary

How does Alpha Cognition compare to Design Therapeutics?

Which has higher valuation & earnings, ACOG or DSGN?

Is ACOG or DSGN more profitable?

Does the media favor ACOG or DSGN?

Do insiders and institutionals have more ownership in ACOG or DSGN?

Which has more risk and volatility, ACOG or DSGN?

Do analysts rate ACOG or DSGN?

Summary

How does Alpha Cognition compare to Aura Biosciences?

Does the media refer more to AURA or ACOG?

Do analysts prefer AURA or ACOG?

Which has better valuation and earnings, AURA or ACOG?

Which has more risk and volatility, AURA or ACOG?

Do insiders & institutionals believe in AURA or ACOG?

Is AURA or ACOG more profitable?

Summary

How does Alpha Cognition compare to Monopar Therapeutics?

Is ACOG or MNPR more profitable?

Do institutionals & insiders believe in ACOG or MNPR?

Does the media prefer ACOG or MNPR?

Do analysts recommend ACOG or MNPR?

Which has stronger earnings & valuation, ACOG or MNPR?

Which has more volatility and risk, ACOG or MNPR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ACOG vs. The Competition

Alpha Cognition Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools